in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—11 February 2014
3:35 AM MST | February 11, 2014 | Deepti Ramesh
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with the fourth quarter of 2012, to $163 million. For the full year 2013, the API business reports a 13% fall in sales, compared with 2012, to $692 million. Earnings figures for the API business were not disclosed. Teva has the largest API business in the world in terms of sales. US FDA commissioner visits India to strengthen cooperation...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee